Nelfinavir is an antiretroviral protease inhibitor used in combination therapy to treat human immunodeficiency virus (HIV) infection by blocking the specific viral protein cleavage required for viral replication.… Read more
![Chemical structure of (3S,4aS,8aS)-2-[(2R,3R)-3-Amino-2-hydroxy-4-(phenylthio)butyl]-N-(1,1-dimethylethyl)decahydro-3-isoquinolinecarboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F159878-05-4-3S4aS8aS-2-2R3R-3-Amino-2-hydroxy-4-phenylthiobutyl-N-11-dimethylethyldecahydro-3-isoquinolinecarboxamide.png&w=3840&q=75)
![Chemical structure of (3S,4aS,8aS)-Decahydro-N-(2-hydroxy-1,1-dimethylethyl)-2-[(2R,3R)-2-hydroxy-3-carbobenzyloxyamino-4-phenylthiobutyl]-3-isoquinolinecarboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F213135-55-8-3S4aS8aS-Decahydro-N-2-hydroxy-11-dimethylethyl-2-2R3R-2-hydroxy-3-carbobenzyloxyamino-4-phenylthiobutyl-3-isoquinolinecarboxamide.png&w=3840&q=75)

![Chemical structure of [3S-(3R,4aR,8aR,2’S,3’S)]-2-[3’-N-t-Boc-amino-2’-hydroxy-4’-(phenyl)thio]butyldecahydroisoquinoline-3-N-t-butylcarboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1217629-57-6-3S-3R4aR8aR2S3S-2-3-N-t-Boc-amino-2-hydroxy-4-phenylthiobutyldecahydroisoquinoline-3-N-t-butylcarboxamide.png&w=3840&q=75)










Nelfinavir is an antiretroviral protease inhibitor used in combination therapy to treat human immunodeficiency virus (HIV) infection by blocking the specific viral protein cleavage required for viral replication. This category provides essential reference standards for the analytical testing, method validation, and quality control of this active pharmaceutical ingredient and its related formulations. Pharmaceutical laboratories rely on these materials, which include pharmacopeial and non-pharmacopeial impurities such as sulfoxide and sulfone derivatives, to conduct accurate impurity profiling and ensure adherence to safety standards. The selection also encompasses stable isotope labelled compounds, which are critical for precise quantification in bioanalytical methods and pharmacokinetic studies. By offering access to the parent drug, relevant degradation products, and process-related impurities, this catalogue supports researchers in maintaining the high-quality benchmarks necessary for the development and monitoring of effective antiretroviral drug therapies.